Key takeaways
- Recurrence after cryotherapy, topical treatment, standard excision or radiotherapy is a different situation from recurrence after Mohs surgery itself, and it’s often handled differently too
- None of these other treatments confirm a clear margin under the microscope in real time the way Mohs surgery does, which is part of why they carry higher recurrence rates
- Cryotherapy and topical treatments in particular carry meaningfully higher recurrence rates than surgical options, even when used appropriately on suitable, low-risk lesions
- Scar tissue or skin changes from an earlier treatment can make a recurrence harder to see and map accurately, which is exactly the kind of case Mohs surgery is built to handle
- When skin cancer returns after one of these treatments, Mohs is often the recommended next step, particularly on the face or in previously treated tissue
You had treatment. Maybe a cream applied over several weeks, maybe freezing in a GP surgery, maybe a straightforward excision at a local clinic. Now something’s changed again in that same spot: a lump, a sore that won’t heal, or a patch that looks like the original mark.
This is a specific, common situation, and it’s worth understanding clearly rather than assuming the worst or hoping it settles on its own. Here’s what’s actually going on, and why Mohs surgery often ends up being the next conversation.
Why This Is a Different Situation From Recurrence After Mohs Surgery
Our guide to recurrence after Mohs surgery itself covers a different scenario: a cancer that was removed with every margin checked under a microscope during the operation, and still came back. That’s uncommon precisely because the margins were confirmed at the time.
Recurrence after cryotherapy, a cream, a standard excision, or radiotherapy is a different starting point. None of these routinely confirm, cell by cell, that every edge of the treated area was clear. That gap is exactly why this situation needs its own explanation.
How Common Is Recurrence After Cryotherapy?
Cryotherapy, freezing the lesion with liquid nitrogen, is a quick, low-cost option still used for some low-risk basal cell carcinomas. A systematic review published in the Dermatology Online Journal found cryotherapy carried a higher recurrence rate than radiotherapy, and that the overall quality of evidence for cryotherapy was limited.
Part of the problem is structural: freezing destroys tissue in place rather than removing it, so there’s no sample to examine afterwards. Success is judged by how the skin looks weeks later, not by confirming a clear margin, which leaves more room for a few surviving cells to go unnoticed.
How Common Is Recurrence After Creams or Photodynamic Therapy?
A Cochrane systematic review covered in the British Journal of Dermatology found imiquimod cream carried roughly ten times the three-year recurrence rate of surgical excision, 16.4% compared with 1.6%. One method of photodynamic therapy reached recurrence rates as high as 36.4% at three years, against 0% for surgery in the same comparison.
These figures aren’t a reason to regret choosing a cream if that was the right call for a genuinely low-risk lesion at the time. Our guide to skin cancer creams vs surgery covers who topical treatment actually suits.
But they explain why recurrence after this route isn’t rare, and why it needs a proper reassessment rather than a repeat course of the same cream.
What About Recurrence After a Standard Surgical Excision?
Standard excision does send tissue to a laboratory, but only cross-sections of the specimen’s edges are typically examined, not every millimetre of the margin. DermNet names incomplete excision or narrow margins as a recognised risk factor for recurrence, alongside more aggressive tumour subtypes and head and neck locations.
DermNet is direct about what happens next: further surgery is recommended for lesions that come back incompletely excised, since a margin report that reads as “clear” can still miss a small cluster of cells sitting just beyond the sampled area.
Why Radiotherapy Failure Is Its Own Particular Case
Radiotherapy can successfully treat skin cancer, including in people for whom surgery isn’t the first choice. But when cells survive and the cancer returns, the skin itself has usually changed: it’s thinner, more fragile, and has a reduced blood supply compared with untreated skin nearby.
Radiation also tends to blur the visual boundary between cancerous and normal-looking tissue, which makes judging the true edge of a recurrence by eye considerably harder than it would be in skin that’s never been treated.
Why These Recurrences Can Be Harder to Assess
Whatever the original treatment, the area you’re looking at now usually isn’t straightforward, untouched skin. Scar tissue from excision, skin changes from radiotherapy, or lingering inflammation from a cream or freezing all distort the normal landmarks a surgeon relies on.
That makes it genuinely harder to tell, just by looking, where the cancer actually starts and stops this time around. Treating it successfully depends on a technique built to handle exactly that kind of uncertainty.
Why Mohs Surgery Is Often Recommended as the Next Step
Mohs micrographic surgery checks 100% of the surgical margin under a microscope during the operation itself, continuing stage by stage until no cancer cells remain at any edge. That makes it particularly well suited to tissue that’s already been disrupted by an earlier treatment.
Rather than guessing at the boundary of a recurrence in scarred or previously irradiated skin, Mohs maps it directly, layer by layer, which is exactly the uncertainty that cryotherapy, topical treatment, standard excision and radiotherapy can each leave behind.
Our guide to which skin cancers Mohs surgery treats covers recurrent and previously treated tumours as one of the situations where it’s most often used.
What to Expect If You’re in This Situation
Your specialist will usually want to confirm the recurrence with a fresh biopsy rather than assuming the new change is the same cancer behaving the same way. It’s helpful to bring details of exactly what your original treatment was and roughly when it happened.
From there, planning tends to cover both removing the recurrence and, if needed, reconstructing the area afterwards, particularly where earlier treatment has already changed the local skin and tissue. Our guide to reconstruction after Mohs surgery covers what that planning typically involves.
When to See a Specialist Promptly
Any new lump, a sore that won’t heal, unusual crusting, or a patch that resembles the original lesion in or near a previously treated site is worth a prompt assessment rather than a wait-and-see approach.
Catching a recurrence early, whatever the original treatment was, generally means a smaller, simpler procedure is needed to deal with it. Our guide to your first visit to a skin cancer surgery clinic explains what that initial assessment involves.
FAQ
Does recurrence after a cream or freezing treatment mean something went wrong?
Not necessarily. These treatments carry higher recurrence rates than surgery even when used correctly on suitable, low-risk lesions. A recurrence reflects the limits of the method, not a mistake in your care.
Can Mohs surgery be done on a previously treated or scarred area?
Yes. Mohs surgery is commonly used on skin that’s been treated before, including scarred, irradiated, or previously excised sites. Its layer-by-layer margin check is well suited to exactly this kind of uncertain tissue.
Is recurrence after standard excision more serious than recurrence after Mohs?
Not automatically. Severity depends more on the tumour’s type, size and location than on which treatment came first. What usually differs is the approach to retreatment, since the surrounding tissue has already been altered.
What if my skin cancer has come back more than once?
A cancer that has recurred before is generally considered higher risk and more likely to need a technique with the most thorough margin control available, which is one of the main reasons Mohs is often recommended at this stage.
Recommended next step
If skin cancer has returned after cryotherapy, a cream, standard excision or radiotherapy, find out more about which skin cancers Mohs surgery treats and whether it’s a suitable next step for your situation.
This article is for general information and does not replace a face-to-face medical assessment. See a doctor promptly about any new or changing mark near a previously treated area.
Filed under Mohs Surgery
